Published in Clin J Pain on January 01, 2008
Clinical features and pathophysiology of complex regional pain syndrome. Lancet Neurol (2011) 1.83
Inflammation in complex regional pain syndrome: a systematic review and meta-analysis. Neurology (2013) 1.20
Role of peripheral endothelin receptors in an animal model of complex regional pain syndrome type 1 (CRPS-I). Pain (2010) 0.90
Neuroinflammation, neuroautoimmunity, and the co-morbidities of complex regional pain syndrome. J Neuroimmune Pharmacol (2012) 0.87
New perspectives on the endothelin axis in pain. Pharmacol Res (2011) 0.84
Facilitated spinal neuropeptide signaling and upregulated inflammatory mediator expression contribute to postfracture nociceptive sensitization. Pain (2015) 0.79
Evidence for the endothelin system as an emerging therapeutic target for the treatment of chronic pain. J Pain Res (2014) 0.77
Sensitive CSF ELISAs for the detection of MBL, MASP-2 and functional MBL/MASP-2. J Neurosci Methods (2012) 0.77
Substance P spinal signaling induces glial activation and nociceptive sensitization after fracture. Neuroscience (2015) 0.76
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord (2008) 9.52
Treatment of vulvar intraepithelial neoplasia with topical imiquimod. N Engl J Med (2008) 4.33
Structures of complement component C3 provide insights into the function and evolution of immunity. Nature (2005) 4.01
Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases. Nat Immunol (2005) 2.82
The inhibiting Fc receptor for IgG, FcγRIIB, is a modifier of autoimmune susceptibility. J Immunol (2011) 2.44
Mannose binding lectin gene polymorphisms confer a major risk for severe infections after liver transplantation. Gastroenterology (2005) 2.30
Lectin complement pathway gene profile of donor and recipient determine the risk of bacterial infections after orthotopic liver transplantation. Hepatology (2010) 2.25
Systematic evaluation of rating scales for impairment and disability in Parkinson's disease. Mov Disord (2002) 2.23
Ketamine produces effective and long-term pain relief in patients with Complex Regional Pain Syndrome Type 1. Pain (2009) 2.22
Drug-induced liver injury following a repeated course of ketamine treatment for chronic pain in CRPS type 1 patients: a report of 3 cases. Pain (2011) 2.13
Efficacy and safety of a single intrathecal methylprednisolone bolus in chronic complex regional pain syndrome. Eur J Pain (2009) 2.12
Genome-wide association study confirms extant PD risk loci among the Dutch. Eur J Hum Genet (2011) 2.12
Allergy is a protective factor against age-related macular degeneration. Invest Ophthalmol Vis Sci (2014) 2.09
Validation of proposed diagnostic criteria (the "Budapest Criteria") for Complex Regional Pain Syndrome. Pain (2010) 2.07
Low bispectral index values in awake volunteers receiving a combination of propofol and midazolam. Anesthesiology (2004) 2.07
Pros and cons for C4d as a biomarker. Kidney Int (2012) 2.03
Large scale production of recombinant human lactoferrin in the milk of transgenic cows. Nat Biotechnol (2002) 1.92
Clinical features and pathophysiology of complex regional pain syndrome. Lancet Neurol (2011) 1.83
Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease. J Am Soc Nephrol (2006) 1.72
Secretory IgA N- and O-glycans provide a link between the innate and adaptive immune systems. J Biol Chem (2003) 1.68
Biochemical and functional characterization of the interaction between pentraxin 3 and C1q. Eur J Immunol (2003) 1.67
Mannose-binding lectin engagement with late apoptotic and necrotic cells. Eur J Immunol (2003) 1.66
The complement system in systemic autoimmune disease. J Autoimmun (2009) 1.64
Opsonization with C1q and mannose-binding lectin targets apoptotic cells to dendritic cells. J Immunol (2004) 1.64
The ventilatory response to hypoxia in mammals: mechanisms, measurement, and analysis. Physiol Rev (2010) 1.63
Pharmacodynamic effect of morphine-6-glucuronide versus morphine on hypoxic and hypercapnic breathing in healthy volunteers. Anesthesiology (2003) 1.61
Modeling the non-steady state respiratory effects of remifentanil in awake and propofol-sedated healthy volunteers. Anesthesiology (2010) 1.59
A randomized prospective study comparing the Cobra Perilaryngeal Airway and Laryngeal Mask Airway-Classic during controlled ventilation for gynecological laparoscopy. Anesth Analg (2007) 1.59
Morphine-6beta-glucuronide rapidly increases pain sensitivity independently of opioid receptor activity in mice and humans. Anesthesiology (2009) 1.57
Reliability and validity of the Beck depression inventory in patients with Parkinson's disease. Mov Disord (2006) 1.57
Multiplex bead array assay for detection of 25 soluble cytokines in blister fluid of patients with complex regional pain syndrome type 1. Mediators Inflamm (2006) 1.55
IL-10-producing macrophages preferentially clear early apoptotic cells. Blood (2006) 1.53
Current knowledge of buprenorphine and its unique pharmacological profile. Pain Pract (2010) 1.53
Direct binding of C1q to apoptotic cells and cell blebs induces complement activation. Eur J Immunol (2002) 1.52
Evidence for local inflammation in complex regional pain syndrome type 1. Mediators Inflamm (2002) 1.50
Assessment of autonomic dysfunction in Parkinson's disease: the SCOPA-AUT. Mov Disord (2004) 1.48
Functional characterization of the lectin pathway of complement in human serum. Mol Immunol (2003) 1.48
Influence of latent risk factors on job satisfaction, job stress and intention to leave in anaesthesia teams: a cross-sectional survey. Eur J Anaesthesiol (2013) 1.46
Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis. Ann Neurol (2011) 1.45
Properdin binds to late apoptotic and necrotic cells independently of C3b and regulates alternative pathway complement activation. J Immunol (2008) 1.44
Development of a symptoms questionnaire for complex regional pain syndrome and potentially related illnesses: the Trauma Related Neuronal Dysfunction Symptoms Inventory. Arch Phys Med Rehabil (2008) 1.44
Pulse dye densitometry and indocyanine green plasma disappearance in ASA physical status I-II patients. Anesth Analg (2010) 1.43
Importance of nondopaminergic features in evaluating disease severity of Parkinson disease. Neurology (2014) 1.43
Expression of beta-defensin 1 and 2 mRNA by human monocytes, macrophages and dendritic cells. Immunology (2002) 1.41
The success of acinetobacter species; genetic, metabolic and virulence attributes. PLoS One (2012) 1.39
Mast cells are involved in inflammatory reactions during Complex Regional Pain Syndrome type 1. Immunol Lett (2004) 1.38
Genotypic and phenotypic characteristics of Dutch patients with early onset Parkinson's disease. Mov Disord (2009) 1.36
The identification of Parkinson's disease subtypes using cluster analysis: a systematic review. Mov Disord (2010) 1.34
Safety and efficacy of ARA 290 in sarcoidosis patients with symptoms of small fiber neuropathy: a randomized, double-blind pilot study. Mol Med (2012) 1.33
Structure and function of the long pentraxin PTX3 glycosidic moiety: fine-tuning of the interaction with C1q and complement activation. Biochemistry (2006) 1.32
Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes. J Clin Invest (2004) 1.31
A functional variant in the CFI gene confers a high risk of age-related macular degeneration. Nat Genet (2013) 1.29
Factor B structure provides insights into activation of the central protease of the complement system. Nat Struct Mol Biol (2007) 1.27
Rapamycin specifically interferes with GM-CSF signaling in human dendritic cells, leading to apoptosis via increased p27KIP1 expression. Blood (2002) 1.26
Ketamine for chronic pain: risks and benefits. Br J Clin Pharmacol (2014) 1.25
Myeloperoxidase is critically involved in the induction of organ damage after renal ischemia reperfusion. Am J Pathol (2007) 1.24
Naloxone treatment in opioid addiction: the risks and benefits. Expert Opin Drug Saf (2007) 1.24
Polymorphism of mu-opioid receptor gene (OPRM1:c.118A>G) does not protect against opioid-induced respiratory depression despite reduced analgesic response. Anesthesiology (2005) 1.23
Increased endothelin-1 and diminished nitric oxide levels in blister fluids of patients with intermediate cold type complex regional pain syndrome type 1. BMC Musculoskelet Disord (2006) 1.22
Rhinovirus increases human beta-defensin-2 and -3 mRNA expression in cultured bronchial epithelial cells. FEMS Immunol Med Microbiol (2003) 1.22
Complement activation by (auto-) antibodies. Mol Immunol (2011) 1.22
Do sex differences exist in opioid analgesia? A systematic review and meta-analysis of human experimental and clinical studies. Pain (2010) 1.21
Risk alleles in CFH and ARMS2 are independently associated with systemic complement activation in age-related macular degeneration. Ophthalmology (2011) 1.20
LL-37 directs macrophage differentiation toward macrophages with a proinflammatory signature. J Immunol (2010) 1.20
Maturation of dendritic cells abrogates C1q production in vivo and in vitro. Blood (2004) 1.20
The membrane attack complex of complement induces caspase activation and apoptosis. Eur J Immunol (2002) 1.20
Inflammation in complex regional pain syndrome: a systematic review and meta-analysis. Neurology (2013) 1.20
Complex regional pain syndrome 1--the Swiss cohort study. BMC Musculoskelet Disord (2008) 1.19
Interactions of the extracellular matrix proteoglycans decorin and biglycan with C1q and collectins. J Immunol (2005) 1.19
Maggot excretions/secretions inhibit multiple neutrophil pro-inflammatory responses. Microbes Infect (2007) 1.19
Clinical subtypes of Parkinson's disease. Mov Disord (2010) 1.18
Sleep and circadian rhythm alterations correlate with depression and cognitive impairment in Huntington's disease. Parkinsonism Relat Disord (2010) 1.18
Recognition and clearance of apoptotic cells: a role for complement and pentraxins. Trends Immunol (2003) 1.17
Connective tissue growth factor and igf-I are produced by human renal fibroblasts and cooperate in the induction of collagen production by high glucose. Diabetes (2003) 1.16
Evaluation of the hospital anxiety and depression scale in patients with Parkinson's disease. Clin Neuropharmacol (2002) 1.15
Antibody-mediated activation of the classical pathway of complement may compensate for mannose-binding lectin deficiency. Eur J Immunol (2004) 1.15
Human peritoneal macrophages show functional characteristics of M-CSF-driven anti-inflammatory type 2 macrophages. Eur J Immunol (2007) 1.14
Mice lacking multidrug resistance protein 3 show altered morphine pharmacokinetics and morphine-6-glucuronide antinociception. Proc Natl Acad Sci U S A (2005) 1.14
Monomethylfumarate affects polarization of monocyte-derived dendritic cells resulting in down-regulated Th1 lymphocyte responses. Eur J Immunol (2004) 1.14
The spectrum of phenotypes caused by variants in the CFH gene. Mol Immunol (2009) 1.13
Complement activation by tubular cells is mediated by properdin binding. Am J Physiol Renal Physiol (2008) 1.12
Therapeutic targeting of classical and lectin pathways of complement protects from ischemia-reperfusion-induced renal damage. Am J Pathol (2010) 1.12
Mini-review: A pivotal role for innate immunity in the clearance of apoptotic cells. Eur J Immunol (2004) 1.11
ARA290, a peptide derived from the tertiary structure of erythropoietin, produces long-term relief of neuropathic pain: an experimental study in rats and β-common receptor knockout mice. Anesthesiology (2011) 1.11
Radiolabelled antimicrobial peptides for infection detection. Lancet Infect Dis (2003) 1.11
Thermographic temperature measurement compared with pinprick and cold sensation in predicting the effectiveness of regional blocks. Anesth Analg (2006) 1.11
Attenuated mild colonic inflammation and improved survival from severe DSS-colitis of transgenic Cu/Zn-SOD mice. Free Radic Biol Med (2003) 1.10
DYT6 dystonia: mutation screening, phenotype, and response to deep brain stimulation. Mov Disord (2010) 1.10
Fatigue rating scales critique and recommendations by the Movement Disorders Society task force on rating scales for Parkinson's disease. Mov Disord (2010) 1.09
Bioacoustics, breaths, and biostatistics. Anesth Analg (2013) 1.09